Primär kutanes diffuses grosszelliges B-Zell-Lymphom (isolierte Herde oder gruppierte Herde)
Zuletzt aktualisiert: 2022-11-16
Autor(en): -
ICD11: 2A81.A
Primär kutanes diffus-grosszelliges B-Zell-Lymphom, leg type.
Zentroblastär und immunoblastär differenziertes, primär kutanes B-Zell Lymphom.
- Häufigkeitsgipfel: 70-80 J.
- Frauen > Männer
Assoziation: Rheumatoide Polyarthritis, chronische Lymphödemen
Meist an den Unterschenkeln auftretende erythematös, derb palpable, teils ulzerierte Knoten.
- Klinik
- Labor
- BSG/CRP, Diff.-BB (Leukozytose, rel. Lymphozytose), Leber- und Nierenwerte, LDH, Elektrolyte
- Borrelienserologie
- Ggf. Immunelektrophorese
- Ggf. HTLV-Serologie
- Biopsie
- Dermatopathologie
- Immunhistologie: CD 19, CD20, CD79a, bcl-6 und CD10 pos. und meist bcl-2 neg.
- Molekularbiologisch: PCR für die Immunglobulinkette
- Lymphknotensonographie, Abdomensonographie, Röntgen-Thorax
- Knochenmarksbiopsie optional
5-Jahresüberlebensrate: 40%
|
Ausdehnung |
Therapie der ersten Wahl |
Therapie der zweiten Wahl |
|
Isolierte Herde oder gruppierte Herde |
Radiotherapie und/oder R-CHOP Exzision |
|
|
Multiple Herde |
R-CHOP |
Doxorubicin oder Gemcitabin, ggf. in Kombination mit Rituximab |
Quelle: Stadler, R., et al., Short German guidelines: cutaneous lymphomas. J Dtsch Dermatol Ges, 2008. 6 Suppl 1: p. S25-31.
Bei Therapieresistenz:
- Chimärer monoklonaler Anti-CD20-Antikörper
- Rituximab i.v. 275 mg/m² KOF (Tag 0, 7, 14, 21)
- Prämedikation:
- Analgetika
- 1000 mg Paracetamol p.o.
1. Annular elastolytic giant-cell granuloma, in SpringerReference. Springer Science + Business Media.
2. Boussault, P., et al., Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma associated with an annular elastolytic giant cell granuloma. British Journal of Dermatology, 2009. 160(5): p. 1126-1128.
3. Di Giacomo, T.B., R.T. Marinho, and M.M.S. Nico, Erythema elevatum diutinum presenting with a giant annular pattern. International Journal of Dermatology, 2009. 48(3): p. 290-292.
4. Fujimura, T., T. Terui, and H. Tagami, Disseminated Papular Interstitial Elastolytic Giant Cell Granuloma. Acta Dermato-Venereologica, 2003. 83(3): p. 234-235.
5. Garg, A., Annular Elastolytic Giant Cell Granuloma Heralding Onset and Recurrence of Acute Myelogenous Leukemia. Arch Dermatol, 2006. 142(4): p. 523.
6. Gonzalez-Gay, M.A., Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Annals of the Rheumatic Diseases, 2001. 60(4): p. 367-371.
7. Gutzmer, R., et al., Successful Therapy of Annular Elastolytic Giant Cell Granuloma with Fumaric Acid Esters. Dermatology, 2002. 205(4): p. 421-424.
8. Harvell, J.D., S.E. Kilpatrick, and W.L. White, Histogenetic Relations Between Giant Cell Fibroblastoma and Dermatofibrosarcoma Protuberans. The American Journal of Dermatopathology, 1998. 20(4): p. 339-345.
9. Jha, P., C. Moosavi, and J.C. Fanburg-Smith, Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger. Annals of Diagnostic Pathology, 2007. 11(2): p. 81-88.
10. Khan, Z.M. and C.J. Cockerell, Atypical Fibroxanthoma with Osteoclast-Like Multinucleated Giant Cells. The American Journal of Dermatopathology, 1997. 19(2): p. 174-179.
11. Lim, K.B. and K.L. Phay, Annular Elastolytic Giant-Cell Granuloma. International Journal of Dermatology, 1987. 26(7): p. 463-464.
12. Lin, J.H., et al., Coexistence of three variants of porokeratosis with multiple squamous cell carcinomas arising from lesions of giant hyperkeratotic porokeratosis. Journal of the European Academy of Dermatology and Venereology, 2006. 20(5): p. 621-623.
13. Müller, F.B. and W. Groth, Annular elastolytic giant cell granuloma: a prodromal stage of mid-dermal elastolysis? Br J Dermatol, 2007. 156(6): p. 1377-1378.
14. Nordborg, C., The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population. Rheumatology, 2003. 42(4): p. 549-552.
15. O'Connell, J.X., J.C. Fanburg, and A.E. Rosenberg, Giant cell tumor of tendon sheath and pigmented villonodular synovitis: Immunophenotype suggests a synovial cell origin. Human Pathology, 1995. 26(7): p. 771-775.
16. ÖZkaya, B., et al., Annular elastolytic giant cell granuloma: sparing of a burn scar and successful treatment with chloroquine. British Journal of Dermatology, 1999. 140(3): p. 525-530.
17. Satti, M.B., Tendon sheath tumours: a pathological study of the relationship between giant cell tumour and fibroma of tendon sheath. Histopathology, 1992. 20(3): p. 213-220.
18. Schwarz, T., R. Lindlbauer, and F. Gschnait, Annular elastolytic giant cell granuloma. J Cutan Pathol, 1983. 10(5): p. 321-326.
19. Tsutsui, K., et al., Annular Elastolytic Giant Cell Granuloma: Response to Cyclosporin A. The Journal of Dermatology, 1994. 21(6): p. 426-429.
20. Vogrincic, G.S., J.X. O'Connell, and C.B. Gilks, Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Human Pathology, 1997. 28(7): p. 815-819.
21. Weyand, C.M. and J.r.J. Goronzy, Arterial wall injury in giant cell arteritis. Arthritis & Rheumatism, 1999. 42(5): p. 844-853.
Diese Website nutzt Cookies!
Um unsere Inhalte optimal an Ihre Bedürfnisse anzupassen und unsere Website kontinuierlich zu verbessern, verwenden wir Cookies. Sie entscheiden selbst, für welche Cookies Sie Ihre Einwilligung geben möchten. Detaillierte Informationen zu den verwendeten Cookies finden Sie in unserer Datenschutzerklärung und den Cookie-Einstellungen. Ihre Einwilligung können Sie jederzeit widerrufen.